People

Guillaume Peyon is Porsolt’s publicly named CNS Study Director. Its September2026 epilepsy-congress announcement describes his presentation of research comparing electrical amygdala-kindling paradigms and antiseizure-compound responses in rats. These are preclinical research models, not demonstrated clinical treatment efficacy.